87
66
Growth Score
-2 pts
Heat Score
-16 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
264677
ALK provides treatment, vaccination, and immunotherapy for allergy.
- Peter Andersen: Senior Vice President of Global Research and Drug DiscoveryPast Role: Symphogen, Director of Antibody Discovery
- Henriette Mersebach: Executive Vice President, Research & Development
About the Company
ALK is a healthcare service provider. They offer products and services via a web shop to help people manage their allergies. It also provides treatment for respiratory allergies that works by treating the underlying cause of the allergy.
